Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christine Priest

Physician Assistant, Medical Marlton, NJ Physician Assistant

NPI 1508803958 CMS profile 10761051

127 Church Rd, 100, Marlton, NJ 08053

Open in the dashboard

General payments

$7,150

410 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christine Priest of Marlton, NJ is reported in the CMS Open Payments database as having received $7,150 across 410 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,487 82
2024 General $1,941 104
2023 General $1,436 84
2022 General $1,552 99
2021 General $734 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christine Priest
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Christine Priest were reported at $1,487. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Christine Priest Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $734 $156 $41–$563 $132
2022 $1,552 $185 $55–$649 $149
2023 $1,436 $199 $58–$717 $160
2024 $1,941 $206 $62–$740 $164
2025 $1,487 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,232 89 payments
  2. Lilly USA, LLC $695 42 payments
  3. Janssen Biotech, Inc. $658 35 payments
  4. Novartis Pharmaceuticals Corporation $535 36 payments
  5. Sun Pharmaceutical Industries Inc. $505 26 payments
  6. E.R. Squibb & Sons, L.L.C. $449 22 payments
  7. Arcutis Biotherapeutics, Inc. $425 14 payments
  8. UCB, Inc. $396 19 payments
  9. Incyte Corporation $374 16 payments
  10. Mayne Pharma Inc. $345 16 payments
  11. Other $1,536 95 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,907 407 payments
  2. Education $243 3 payments
Products named General payments · program years 2021–2025
  1. TALTZ $626 38 payments
  2. SKYRIZI $566 46 payments
  3. TREMFYA $545 26 payments
  4. SOTYKTU $449 22 payments
  5. COSENTYX $433 29 payments
  6. RINVOQ $414 31 payments
  7. Zoryve $378 11 payments
  8. OPZELURA $374 16 payments
  9. ILUMYA $345 21 payments
  10. OLUMIANT $334 20 payments
  11. Other $3,626 229 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

613

Median for Physician Assistant: 241

Drug cost

$30,419

Median for Physician Assistant: $4,110

Branded share of claims

14%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jublia Efinaconazole Brand 11 $12,846
Clobetasol Propionate Generic 58 $3,185
Tacrolimus Generic 30 $3,161
Fluorouracil Generic 34 $2,117
Ciclopirox Ciclopirox Olamine Brand 64 $1,475
Metronidazole Generic 34 $1,026
Clindamycin Phosphate Generic 41 $973
Ciclopirox Generic 28 $938
Triamcinolone Acetonide Generic 83 $915
Betamethasone Dipropionate Generic 26 $835

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$105,478

Of which drugs: $1,621

Medicare patients

596

Average age 74

Services billed

3,983

429 women, 167 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 42%
Diabetes 21%
Ischemic heart disease 21%
Cancer 18%
Depression 15%
Osteoporosis 15%
Atrial fibrillation 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 14 32 $23

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 20 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Zoryve
  • Arcutis Biotherapeutics, Inc. $347
$347 — —
Bimzelx
  • UCB, Inc. $193
$193 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $181
$181 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $176
$176 — —
SKYRIZI
  • AbbVie, Inc. $155
$155 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 20 in the dashboard with a free account

Records

410 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record